Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Melatonin  COVID-19 treatment studies for Melatonin  C19 studies: Melatonin  Melatonin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Vitamin D, Melatonin, Vitamin C, and Viscum Album
Hancock et al., SSRN, doi:10.2139/ssrn.3779211 (Preprint)
Hancock et al., Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Vitamin D,.., SSRN, doi:10.2139/ssrn.3779211 (Preprint)
Feb 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Case series of 24 COVID-19 patients (12 confirmed PCR+) treated with vitamin D, vitamin C, and melatonin, showing positive outcomes with no patient having worse than a mild case, including 7 high risk patients.
Hancock et al., 9 Feb 2021, preprint, 4 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperMelatoninAll
Abstract: Vitamin D, Melatonin, Vitamin C, and Viscum Album iew ed Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Authors: Mark Hancock MD MPH1, Petra Ketterl MD1, Xavier Vinas2, Paul Werthmann MD3,4,5 Institutions: HUMANIZING MEDICINE, 135 Maple Street, Building A, Decatur, GA, US 2 Xavier Viñas Design, Decatur, GA, US 3 Center for Complementary Medicine – University of Freiburg, Faculty of Medicine, University of 4 Institute for Applied Epistemology and Medical Methodology at the University of Witten/Herdecke, Zechenweg 6, D-79111 Freiburg i.Brsg., Germany Department of General and Visceral Surgery, University Hospital Ulm, Ulm, Germany pe 5 er r Freiburg, Breisacherstr. 115B, 79106 Freiburg, Germany ev 1 Corresponding author: Mark Hancock MD MPH, HUMANIZING MEDICINE, 135 Maple Street, Building Pr ep rin tn ot A, Decatur, GA, US, mark@humanizingmedicine.com This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=3779211 Abstract iew ed Background: The SARS-COV-2 global pandemic has been noted to have a differential effect on those exposed depending on risk factors such as age, diabetes, cardiovascular disease and cancer. Case presentation: We report a case series of 12 confirmed positive patients and 12 presumptive positive patients all of whom had either an entirely asymptomatic or relatively mild clinical course. 2 patients had active cancer, 3 patients were cancer survivors, 1 patient without cancer was 74 years old. All patients were treated early in their disease course with vitamin D loading (50,000iu daily for 3 ev days), 60 to 240mg melatonin, and 2000mg oral vitamin C. The 6 high risk patients and one 59 year old patient were treated with at least 2 intravenous doses of vitamin C. The 2 patients with active cancer received 75 grams of vitamin C (one daily, the other every other day). All of the high risk patients had er r a nearly asymptomatic clinical course and were tested after 10 days and all had a RT PCR for COVID-19 that was negative. The 17 remaining patients also had a relatively benign course though 4 patients (2 in their 20s, 2 in their 50s) received this treatment course later in the course of their illness, these were notably the only patients who had more than a mild sore throat or low grade fever. pe Conclusion: We report these unexpectedly positive clinical outcomes of COVID-19 patients including patients with different risk factors, under supplemental vitamin C and D and melatonin. These supplements have a favorable safety profile and are already being suggested as potentially disease tn ot altering therapies in the ongoing COVID-19 pandemic. Pr ep rin Key Words: COVID-19, Cancer, Vitamin D, Melatonin, Vitamin C This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=3779211
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit